Medical College of Wisconsin Cancer Center Leads Groundbreaking Change in Medicare Policy for MDS Patients Over 65 in Need of Lifesaving Transplants
May 09, 2024
May 09, 2024
MILWAUKEE, Wisconsin, May 9 (TNSres) -- The Medical College of Wisconsin issued the following news:
The Centers for Medicare & Medicaid Services recently issued a decision to expand Medicare coverage for allogeneic hematopoietic stem cell transplants (HCT) for eligible Medicare patients with myelodysplastic syndromes (MDS), based on decades-long research led by investigators at the Medical College of Wisconsin (MCW) Cancer Center, in collaboration with investigators in the Blood . . .
The Centers for Medicare & Medicaid Services recently issued a decision to expand Medicare coverage for allogeneic hematopoietic stem cell transplants (HCT) for eligible Medicare patients with myelodysplastic syndromes (MDS), based on decades-long research led by investigators at the Medical College of Wisconsin (MCW) Cancer Center, in collaboration with investigators in the Blood . . .